Cargando…
Defining multimorbidity in people with HIV – what matters most?
Although multimorbidity (defined as the coexistence of multiple conditions) presents significant health challenges to people with HIV, there is currently no consensus on how it should be defined among this population. This review aimed to examine the definition of multimorbidity in existing studies...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9894144/ https://www.ncbi.nlm.nih.gov/pubmed/36655695 http://dx.doi.org/10.1097/COH.0000000000000778 |
_version_ | 1784881679751446528 |
---|---|
author | Sukumaran, Luxsena Sabin, Caroline A. |
author_facet | Sukumaran, Luxsena Sabin, Caroline A. |
author_sort | Sukumaran, Luxsena |
collection | PubMed |
description | Although multimorbidity (defined as the coexistence of multiple conditions) presents significant health challenges to people with HIV, there is currently no consensus on how it should be defined among this population. This review aimed to examine the definition of multimorbidity in existing studies among people with HIV (n = 22). RECENT FINDINGS: Variation in the definition of multimorbidity (in terms of the number and nature of conditions included) across studies among people with HIV was observed, with less than half (45%) reporting a selection criteria for conditions. The number of conditions considered ranged from 4 to 65. Certain conditions (e.g. stroke, myocardial infarction and chronic kidney disease) and risk factors (e.g. hypertension) were more frequently included, while other symptoms (e.g. joint pain, peripheral neuropathy and sleeping problems) and mental health conditions (e.g. anxiety and panic attacks) were rarely included in the definition of multimorbidity. SUMMARY: The definition of multimorbidity among people with HIV is highly variable, with certain conditions overlooked. We propose recommendations that researchers should consider when defining multimorbidity among this population to not only enable comparisons between studies/settings but also to ensure studies consider a person-centred approach that can accurately capture multimorbidity among people with HIV. |
format | Online Article Text |
id | pubmed-9894144 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Lippincott Williams & Wilkins |
record_format | MEDLINE/PubMed |
spelling | pubmed-98941442023-02-07 Defining multimorbidity in people with HIV – what matters most? Sukumaran, Luxsena Sabin, Caroline A. Curr Opin HIV AIDS CO-MORBIDITIES: Edited by Patrick W. G. Mallon Although multimorbidity (defined as the coexistence of multiple conditions) presents significant health challenges to people with HIV, there is currently no consensus on how it should be defined among this population. This review aimed to examine the definition of multimorbidity in existing studies among people with HIV (n = 22). RECENT FINDINGS: Variation in the definition of multimorbidity (in terms of the number and nature of conditions included) across studies among people with HIV was observed, with less than half (45%) reporting a selection criteria for conditions. The number of conditions considered ranged from 4 to 65. Certain conditions (e.g. stroke, myocardial infarction and chronic kidney disease) and risk factors (e.g. hypertension) were more frequently included, while other symptoms (e.g. joint pain, peripheral neuropathy and sleeping problems) and mental health conditions (e.g. anxiety and panic attacks) were rarely included in the definition of multimorbidity. SUMMARY: The definition of multimorbidity among people with HIV is highly variable, with certain conditions overlooked. We propose recommendations that researchers should consider when defining multimorbidity among this population to not only enable comparisons between studies/settings but also to ensure studies consider a person-centred approach that can accurately capture multimorbidity among people with HIV. Lippincott Williams & Wilkins 2023-03 2023-01-19 /pmc/articles/PMC9894144/ /pubmed/36655695 http://dx.doi.org/10.1097/COH.0000000000000778 Text en Copyright © 2022 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License 4.0 (CCBY), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. http://creativecommons.org/licenses/by/4.0 (https://creativecommons.org/licenses/by/4.0/) |
spellingShingle | CO-MORBIDITIES: Edited by Patrick W. G. Mallon Sukumaran, Luxsena Sabin, Caroline A. Defining multimorbidity in people with HIV – what matters most? |
title | Defining multimorbidity in people with HIV – what matters most? |
title_full | Defining multimorbidity in people with HIV – what matters most? |
title_fullStr | Defining multimorbidity in people with HIV – what matters most? |
title_full_unstemmed | Defining multimorbidity in people with HIV – what matters most? |
title_short | Defining multimorbidity in people with HIV – what matters most? |
title_sort | defining multimorbidity in people with hiv – what matters most? |
topic | CO-MORBIDITIES: Edited by Patrick W. G. Mallon |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9894144/ https://www.ncbi.nlm.nih.gov/pubmed/36655695 http://dx.doi.org/10.1097/COH.0000000000000778 |
work_keys_str_mv | AT sukumaranluxsena definingmultimorbidityinpeoplewithhivwhatmattersmost AT sabincarolinea definingmultimorbidityinpeoplewithhivwhatmattersmost |